APGE Apogee Therapeutics, Inc.
Healthcare$82.81+2.03%ClosedMarket Cap: $5.12B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.50
P/S
0.00
EV/EBITDA
-15.39
DCF Value
$2.00
FCF Yield
-4.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-32.6%
ROA
-21.2%
ROIC
-24.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-82.8M | $-74.1M | $— | — |
| Q4 null | $0.00 | Infinity% | $-78.1M | $-69.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-285.6M | $-255.8M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-71.3M | $-65.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-73.2M | $-66.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-63.1M | $-55.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-75.9M | $-67.2M | $— | — |
| FY null | $0.00 | NaN% | $-216.9M | $-182.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-58.7M | $-49.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-44.1M | $-33.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-38.2M | $-32.1M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-37.2M | $-31.7M | $-0.63 | — |